MRK vs EW
By Alex · Tickerpine
Merck & Company, Inc. vs Edwards Lifesciences Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | EW |
|---|---|---|
| Price | $132.92 | $93.05 |
| Market cap | $327.94B | $53.63B |
| P/E ratio | 106.3 | 55.7 |
| ROE | 6.96% | 9.18% |
| Profit margin | 4.77% | 15.43% |
| Revenue growth | 5.10% | 13.60% |
| Dividend yield | 2.56% | — |
| Beta | 0.21 | 0.85 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs EW in plain English
- MRK is the bigger company — about 6.1× the market cap of EW.
- EW is cheaper on earnings (P/E 55.7 vs 106.3).
- EW earns a higher return on equity (9% vs 7%).
- EW is growing revenue faster (14% vs 5%).
- MRK pays a dividend (2.56%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
EW return calculator
See what $1,000 in Edwards Lifesciences Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.